Dean H. Gesme

1.9k total citations
33 papers, 1.4k citations indexed

About

Dean H. Gesme is a scholar working on Oncology, Economics and Econometrics and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Dean H. Gesme has authored 33 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 10 papers in Economics and Econometrics and 8 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Dean H. Gesme's work include Economic and Financial Impacts of Cancer (10 papers), Cancer survivorship and care (4 papers) and Health Systems, Economic Evaluations, Quality of Life (4 papers). Dean H. Gesme is often cited by papers focused on Economic and Financial Impacts of Cancer (10 papers), Cancer survivorship and care (4 papers) and Health Systems, Economic Evaluations, Quality of Life (4 papers). Dean H. Gesme collaborates with scholars based in United States, Canada and New Zealand. Dean H. Gesme's co-authors include Danette Hann, Maxine M. Denniston, Thomas J. Flynn, Frank Baker, Douglas Reding, Ralph Levitt, James B. Gerstner, James E. Krook, T Buroker and John Kennedy and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Journal of Psychosomatic Research.

In The Last Decade

Dean H. Gesme

32 papers receiving 1.4k citations

Peers

Countries citing papers authored by Dean H. Gesme

Since Specialization

Citations

This map shows the geographic impact of Dean H. Gesme's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dean H. Gesme with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dean H. Gesme more than expected).

Fields of papers citing papers by Dean H. Gesme

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dean H. Gesme. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dean H. Gesme. The network helps show where Dean H. Gesme may publish in the future.

Co-authorship network of co-authors of Dean H. Gesme

This figure shows the co-authorship network connecting the top 25 collaborators of Dean H. Gesme. A scholar is included among the top collaborators of Dean H. Gesme based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dean H. Gesme. Dean H. Gesme is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Creating Virtual Integration and Improved Oncology Care Quality Through a Co-Management Services Agreement 2016 ·Journal of Oncology Practice ·(unknown), (unknown), (unknown), Dean H. Gesme	1
2	Second-Line Treatment Outcomes After First-Line Sunitinib Therapy in Metastatic Renal Cell Carcinoma 2012 ·Clinical Genitourinary Cancer ·Chi‐Chang Chen, Gregory P. Hess, Zhimei Liu, Dean H. Gesme, Sanjiv S. Agarwala, (unknown), Jerrold Hill, Amy Guo	18
3	Advance Care Planning With Your Patients 2011 ·Journal of Oncology Practice ·Dean H. Gesme, (unknown)	7
4	Subspecialization in Community Oncology: Option or Necessity? 2011 ·Journal of Oncology Practice ·Dean H. Gesme, (unknown)	12
5	Essentials of Staff Development and Why You Should Care 2010 ·Journal of Oncology Practice ·Dean H. Gesme, (unknown), (unknown)	18
6	Effect of changes in labeling and reimbursement on use of ESAs and transfusions 2008 ·Journal of Clinical Oncology ·Gregory P. Hess, Robert J. Nordyke, Melissa Pirolli, (unknown), (unknown), Dean H. Gesme	4
7	Assessing Communication Between Oncology Professionals and Their Patients 2005 ·Journal of Cancer Education ·Cleora S. Roberts, Harold Benjamin, Liddy Chen, Molly Gavigan, Dean H. Gesme, (unknown), Robert J. Samuels, Walter F. Baile	32
8	Is absolute amount or change in exercise more associated with quality of life in adult cancer survivors? 2003 ·Preventive Medicine ·Chris M. Blanchard, Frank Baker, Maxine M. Denniston, Kerry S. Courneya, Danette Hann, Dean H. Gesme, Douglas Reding, Thomas J. Flynn, John Kennedy	37
9	Phase II Trial of Procarbazine, Lomustine, and Vincristine as Initial Therapy for Patients With Low-Grade Oligodendroglioma or Oligoastrocytoma: Efficacy and Associations With Chromosomal Abnormalities 2003 ·Journal of Clinical Oncology ·Jan C. Buckner, Dean H. Gesme, Judith R. OʼFallon, Julie E. Hammack, (unknown), Paul D. Brown, Roland B. Hawkins, Bernd W. Scheithauer, Bradley J. Erickson, Ralph Levitt, Edward G. Shaw, Robert B. Jenkins	180
10	Do Adults Change Their Lifestyle Behaviors After a Cancer Diagnosis? 2003 ·American Journal of Health Behavior ·Chris M. Blanchard, Maxine M. Denniston, Frank Baker, (unknown), Kerry S. Courneya, Danette Hann, Dean H. Gesme, Douglas Reding, Thomas J. Flynn, John Kennedy	210
11	The influence of social support on depressive symptoms in cancer patients 2002 ·Journal of Psychosomatic Research ·Danette Hann, Frank Baker, Maxine M. Denniston, Dean H. Gesme, Douglas Reding, Thomas J. Flynn, John F. Kennedy, (unknown)	123
12	Purchasing oncology services 2000 ·Cancer ·(unknown), (unknown), (unknown), Terri B. Ades, Charles L. Bennett, Kay Dickersin, Dean H. Gesme, I. Craig Henderson, Lamar S. McGinnis, Kathi Mooney, (unknown), Paul W. Sperduto, William Winkenwerder, David J. Ballard	6
13	Growth of Oncology Physician Practice Management Companies 1999 ·Cancer Investigation ·(unknown), Dean H. Gesme, Robert M. Rifkin, (unknown)	2
14	A randomized Phase II trial of two dosage levels of letrozole as third-line hormonal therapy for women with metastatic breast carcinoma 1997 ·Cancer ·James N. Ingle, Patricia Johnson, Vera J. Suman, James B. Gerstner, James A. Mailliard, John Camoriano, Dean H. Gesme, Charles L. Loprinzi, Alan K. Hatfield, Lynn C. Hartmann	52
15	Estrogen and Progesterone Receptors in Primary Breast Cancer 1996 ·The Breast Journal ·Sue A. Joslyn, Dean H. Gesme, Charles F. Lynch	5
16	Randomized placebo-controlled evaluation of hydrazine sulfate in patients with advanced colorectal cancer. 1994 ·Journal of Clinical Oncology ·Charles L. Loprinzi, Steven A. Kuross, Judith R. OʼFallon, Dean H. Gesme, James B. Gerstner, Raylene M. Rospond, Charles D. Cobau, Richard M. Goldberg	69
17	Randomized comparison of two schedules of fluorouracil and leucovorin in the treatment of advanced colorectal cancer. 1994 ·Journal of Clinical Oncology ·T Buroker, M J O'Connell, Harry S. Wieand, James E. Krook, James B. Gerstner, J A Mailliard, (unknown), Ralph Levitt, Carl G. Kardinal, Dean H. Gesme	248
18	A randomized phase II trial of amonafide or trimetrexate in patients with advanced non-small cell lung cancer. A trial of the north central cancer treatment group 1993 ·Cancer ·Dean H. Gesme, James R. Jett, (unknown), John Q. Su, James A. Mailliard, John Foley, James E. Krook, Andrew W. Maksymiuk, Alan K. Hatfield, Larry P. Ebbert, Delano M. Pfeifle, Roscoe F. Morton, Loren K. Tschetter, (unknown)	15
19	A randomized prospective assessment of recombinant leukocyte A human interferon with or without aspirin in advanced renal adenocarcinoma. 1991 ·Journal of Clinical Oncology ·Edward T. Creagan, Donald I. Twito, (unknown), Daniel J. Schaid, Patrick S. Johnson, Morris A. Flaum, T Buroker, L. Geeraerts, M H Veeder, Dean H. Gesme	42
20	A double-blind trial of tamoxifen plus prednisolone versus tamoxifen plus placebo in postmenopausal women with metastatic breast cancer. A collaborative trial of the north central cancer treatment group and mayo clinic 1991 ·Cancer ·James N. Ingle, Harry J. Long, Charles L. Loprinzi, James A. Mailliard, Daniel J. Schaid, James E. Krook, Robert J. Dalton, Dean H. Gesme, (unknown), Delano M. Pfeifle, (unknown), (unknown), John Foley	30

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact